Skip to main content
. 2020 May 12;41(5):733–755. doi: 10.1210/endrev/bnaa015

Table 5.

Currently available follow-on biologic or biosimilar U-100 insulins.

Product Name Manufacturer Reference Product Molecule Approvals
Follow-on biologic/biosimilar insulins
Basaglar®, Abasaglar® Eli Lilly Lantus® Insulin glargine FDA 2015; EMU 2014
Basalin® Gan & Lee Lantus® Insulin glargine China 2005
Semglee® Biocon/Mylan Lantus® Insulin glargine FDA under review; EU, Australia 2018
Admelog® Sanofi Humalog® Insulin lispro FDA 2017